Multiple vaccination including serogroup C meningococcus

• 收藏
• 分享

专利权人:

NOVARTIS VACCINES AND DIAGNOSTICS GMBH & CO. KG

发明人:

BORKOWSKI, ASTRID

申请号：

NZ59836706

公开号：

NZ598367A

申请日:

2006.09.01

申请国别(地区):

NZ

年份:

2013

代理人:

摘要：

NZ 598367 Disclosed is the use of a first immunogenic component and a second immunogenic component in the manufacture of a medicament for the prevention of diptheria, tetanus, infection by B. pertussis and infection by N. meningitidis, wherein: the first immunogenic component comprises an aqueous formulation of a diphtheria toxoid, a tetanus toxoid and acellular B. pertussis antigen and the second immunogenic component comprises a conjugated capsular saccharide from an OAc+ strain of N. meningitidis serogroup C and a conjugated Hib antigen, in lyophilised form.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/